Nomura Holdings
DNA icon

Nomura Holdings’s Ginkgo Bioworks DNA Stock Holding History

Nomura Holdings’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-371
Closed -$26.8K – 1823
2023
Q3 		$26.8K Sell
371
-494
-57% -$39.5K ﹤0.01% 1310
2023
Q2 		$64.3K Sell
865
-1,670
-66% -$98.9K ﹤0.01% 1241
2023
Q1 		$135K Sell
2,535
-39
-2% -$2.47K ﹤0.01% 1264
2022
Q4 		$174K Buy
+2,574
New +$237K ﹤0.01% 1123
2021
Q4 		– Sell
-2,500
Closed -$1.15M – 2291
2021
Q3 		$1.15M Buy
+2,500
New +$1.22M ﹤0.01% 1073

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nomura Holdings's DNA Position: Q4 2023 in Review

Nomura Holdings sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 371 shares — an estimated $26.8K sold.

Nomura Holdings first reported a position in DNA in Q3 2021 and held it in 5 quarters. The position peaked at $1.15M in Q3 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • Nomura Holdings reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • Nomura Holdings sold 371 Ginkgo Bioworks shares in Q4 2023, an estimated $26.8K.
  • Nomura Holdings first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 5 quarters.
  • Nomura Holdings's Ginkgo Bioworks position peaked at $1.15M in Q3 2021.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Nomura Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.